Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | PTK2B | Q14289 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.52 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.52 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | GGT1 | P19440 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14964190 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2APTK2BKDM4ELMNA | |
| SCHEMBL30211332 | 0.94 | ALDH1A1 (0.89) | ALDH1A1KMT2APTK2BKDM4ELMNA | |
| SCHEMBL2049483 | 0.94 | ALDH1A1 (0.89) | ALDH1A1KMT2APTK2BKDM4ELMNA | |
| SCHEMBL28960966 | 0.93 | ALDH1A1 (0.87) | ALDH1A1KMT2APTK2BKDM4ELMNA | |
| SCHEMBL6042573 | 0.92 | ALDH1A1 (0.84) | ALDH1A1KMT2APTK2BKDM4ELMNA | |
| SCHEMBL29013661 | 0.92 | ALDH1A1 (0.84) | ALDH1A1KMT2APTK2BKDM4ELMNA | |
| SCHEMBL25788066 | 0.92 | ALDH1A1 (0.84) | ALDH1A1KMT2APTK2BKDM4ELMNA | |
| SCHEMBL27642091 | 0.90 | ALDH1A1 (0.81) | ALDH1A1KMT2APTK2BKDM4ELMNA | |
| SCHEMBL31603883 | 0.89 | ALDH1A1 (0.79) | ALDH1A1KMT2APTK2BKDM4ELMNA | |
| SCHEMBL212173 | 0.88 | ALDH1A1 (0.79) | ALDH1A1KMT2APTK2BKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220411463-A1 | MATE AND SEPARATE: A CONVENIENT AND GENERAL METHOD FOR THE SEPARATION AND PURIFICATION OF TARGET MOLECULES FROM BIOLOGICAL MEDIA BY PHASE TRANSITION OF PEGYLATED RECOGNITION AGENTS. | KARIMIAN, KHASHAYAR (IR) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411463-A1 | MATE AND SEPARATE: A CONVENIENT AND GENERAL METHOD FOR THE SEPARATION AND PURIFICATION OF TARGET MOLECULES FROM BIOLOGICAL MEDIA BY PHASE TRANSITION OF PEGYLATED RECOGNITION AGENTS. | TPR, STAMBP, NASP | ALDH1A1 4848/4885KMT2A 3905/4885PTK2B 4189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.